kabutan

PhoenixBio, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Loss Widens

Fri Feb 14, 2025 3:30 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE Growth] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending March 2025 (April to December) turned into a loss of 146 million yen (compared to a profit of 32 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 131 million yen (compared to a profit of 11 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary loss expanded to a loss of 23 million yen (compared to a loss of 13 million yen in the same period last year). The operating profit/loss margin drastically worsened from 7.8% in the same period last year to -15.5%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 1,660 464 446 393 117.7 87.3 Feb 14, 2023 J-GAAP
Apr - Dec, 2023 1,328 30 32 14 3.9 74.4 Feb 14, 2024 J-GAAP
Apr - Dec, 2024 1,143 -153 -146 -150 -37.3 ー Feb 14, 2025 J-GAAP
YoY -13.9% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 834 16 -2 -1 -0.3 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 733 -155 -154 -157 -38.8 0 Nov 14, 2024 J-GAAP
YoY -12.1% － -7,600.0% -15,600.0% -14,255.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,124 508 511 493 145.2 0 May 15, 2023 J-GAAP
Mar, 2024 1,715 11 43 26 7.0 0 May 15, 2024 J-GAAP
Mar, 2025 Guidance 1,521 -253 -277 -281 -69.4 0 Nov 14, 2024 J-GAAP
YoY -11.3% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 447 35 -13 -13 -3.6 7.8 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 387 -19 11 12 3.2 -4.9 May 15, 2024 J-GAAP
Apr - Jun, 2024 449 5 25 23 5.8 1.1 Aug 13, 2024 J-GAAP
Jul - Sep, 2024 339 -103 -148 -147 -36.6 -30.4 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 355 -55 -23 -26 -6.5 -15.5 Feb 14, 2025 J-GAAP
YoY -20.6% － -76.9% -100.0% -78.9%

Related Articles